- Home
- YIBO vs IMAB Comparison
YIBO vs IMAB Comparison
Compare YIBO & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- IMAB
- Stock Information
- Founded
- YIBO 2011
- IMAB 2014
- Country
- YIBO China
- IMAB United States
- Employees
- YIBO N/A
- IMAB N/A
- Industry
- YIBO
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- YIBO
- IMAB Health Care
- Exchange
- YIBO NYSE
- IMAB Nasdaq
- Market Cap
- YIBO 75.4M
- IMAB 73.9M
- IPO Year
- YIBO 2024
- IMAB 2020
- Fundamental
- Price
- YIBO $1.49
- IMAB $2.50
- Analyst Decision
- YIBO
- IMAB Strong Buy
- Analyst Count
- YIBO 0
- IMAB 2
- Target Price
- YIBO N/A
- IMAB $5.50
- AVG Volume (30 Days)
- YIBO 113.4K
- IMAB 1.0M
- Earning Date
- YIBO 06-27-2025
- IMAB 05-15-2025
- Dividend Yield
- YIBO N/A
- IMAB N/A
- EPS Growth
- YIBO N/A
- IMAB N/A
- EPS
- YIBO 0.13
- IMAB N/A
- Revenue
- YIBO $149,828,000.00
- IMAB N/A
- Revenue This Year
- YIBO N/A
- IMAB N/A
- Revenue Next Year
- YIBO N/A
- IMAB N/A
- P/E Ratio
- YIBO $11.15
- IMAB N/A
- Revenue Growth
- YIBO N/A
- IMAB N/A
- 52 Week Low
- YIBO $0.95
- IMAB $0.60
- 52 Week High
- YIBO $17.47
- IMAB $3.08
- Technical
- Relative Strength Index (RSI)
- YIBO 54.61
- IMAB 67.42
- Support Level
- YIBO $1.25
- IMAB $2.29
- Resistance Level
- YIBO $1.72
- IMAB $2.69
- Average True Range (ATR)
- YIBO 0.12
- IMAB 0.35
- MACD
- YIBO 0.01
- IMAB 0.00
- Stochastic Oscillator
- YIBO 70.23
- IMAB 64.53
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under four brands, TrueImage, CoolToner, AZtech, and Toner Bank. The company operates in North America, Europe, and Other countries.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).